Frontiers in Genetics (Feb 2024)

Diagnostic utility of DNA methylation episignature analysis for early diagnosis of KMT2B-related disorders: case report

  • Nadia Bouhamdani,
  • Nadia Bouhamdani,
  • Nadia Bouhamdani,
  • Nadia Bouhamdani,
  • Haley McConkey,
  • Haley McConkey,
  • Amélie Leblanc,
  • Amélie Leblanc,
  • Amélie Leblanc,
  • Bekim Sadikovic,
  • Bekim Sadikovic,
  • Mouna Ben Amor,
  • Mouna Ben Amor,
  • Mouna Ben Amor

DOI
https://doi.org/10.3389/fgene.2024.1346044
Journal volume & issue
Vol. 15

Abstract

Read online

The lysine methyltransferase 2B (KMT2B) gene product is important for epigenetic modifications associated with active gene transcription in normal development and in maintaining proper neural function. Pathogenic variants in KMT2B have been associated with childhood-onset Dystonia-28 and Intellectual developmental disorder, autosomal dominant 68 (MRD 68) for cases of neurodevelopmental impairment without dystonia (DYT28; OMIM 617284 and MRD68; OMIM 619934, respectively). Since its first description in 2016, approximately one hundred KMT2B genetic variants have been reported with heterogeneous phenotypes, including atypical patterns of dystonia evolution and non-dystonic neurodevelopmental phenotypes. KMT2B-related disorders share many overlapping phenotypic characteristics with other neurodevelopmental disorders and delayed dystonia, that can appear later in childhood, often delaying clinical diagnosis. Furthermore, conventional genetic testing may not always provide actionable information (e.g., gene panel selection based on early clinical presentation or variants of uncertain significance), which prevents patients and families from obtaining early access to treatments and support. Herein, we describe the early diagnosis of KMT2B-related neurodevelopmental disorder by DNA methylation episignature testing in a 4-year-old patient without features of dystonia at diagnosis, which is reported to develop in more than 80% of KMT2B-related disorder cases. The proband, a 4-year-old female of Jewish-Israeli descent, presented with speech delay, microcephaly, poor weight gain, attention-deficit and hyperactivity disorder, dysmorphism, intellectual disabilities and joint hyperlaxity, but presented no signs of dystonia at initial evaluation. Episignature screening in this pre-symptomatic patient enabled accurate genetic diagnosis and timely and actionable intervention earlier in the natural history of Childhood-onset Dystonia-28.

Keywords